TY - JOUR
T1 - Validation of Two Activity Monitors in Slow and Fast Walking Hospitalized Patients
AU - Pedersen, Britt Stævnsbo
AU - Kristensen, Morten Tange
AU - Josefsen, Christian Ohrhammer
AU - Lykkegaard, Kasper Lundberg
AU - Jønsson, Line Rokkedal
AU - Pedersen, Mette Merete
N1 - Copyright © 2022 Britt Stævnsbo Pedersen et al.
PY - 2022
Y1 - 2022
N2 - To evaluate interventions to promote physical activity, valid outcome measures are important. This study evaluated the validity and reliability of the ActivPAL3™ and the SENS motion® activity monitors with regard to the number of steps taken, walking, and sedentary behavior in hospitalized patients (n = 36) (older medical patients (+65 years) (n = 12), older patients (+65) with acute hip fracture (n = 12), and patients (+18) who underwent acute high-risk abdominal surgery (n = 12)). Both monitors showed good (≥60%) percentage agreement with direct observation for standing and no. of steps (all gait speeds) and high agreement (≥80%) for lying. For walking, ActivPAL3™ showed moderate percentage agreement, whereas SENS motion® reached high percentage agreement. The relative reliability was moderate for sedentary behavior for both monitors. The ActivPAL3™ showed poor (walking) to moderate (steps) reliability for walking and steps, whereas SENS motion® showed moderate reliability for both activities. For slow walkers, the relative reliability was moderate for SENS motion® and poor for ActivPAL3™. This trial is registered with the ClinicalTrials.gov identifier NCT04120740.
AB - To evaluate interventions to promote physical activity, valid outcome measures are important. This study evaluated the validity and reliability of the ActivPAL3™ and the SENS motion® activity monitors with regard to the number of steps taken, walking, and sedentary behavior in hospitalized patients (n = 36) (older medical patients (+65 years) (n = 12), older patients (+65) with acute hip fracture (n = 12), and patients (+18) who underwent acute high-risk abdominal surgery (n = 12)). Both monitors showed good (≥60%) percentage agreement with direct observation for standing and no. of steps (all gait speeds) and high agreement (≥80%) for lying. For walking, ActivPAL3™ showed moderate percentage agreement, whereas SENS motion® reached high percentage agreement. The relative reliability was moderate for sedentary behavior for both monitors. The ActivPAL3™ showed poor (walking) to moderate (steps) reliability for walking and steps, whereas SENS motion® showed moderate reliability for both activities. For slow walkers, the relative reliability was moderate for SENS motion® and poor for ActivPAL3™. This trial is registered with the ClinicalTrials.gov identifier NCT04120740.
UR - http://www.scopus.com/inward/record.url?scp=85131189814&partnerID=8YFLogxK
U2 - 10.1155/2022/9230081
DO - 10.1155/2022/9230081
M3 - Journal article
C2 - 35615755
SN - 2090-2867
VL - 2022
SP - 9230081
JO - Rehabilitation research and practice
JF - Rehabilitation research and practice
M1 - 9230081
ER -